Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial
Research output: Contribution to journal › Article › peer-review
21Scopus
citations
Fingerprint
Dive into the research topics of 'Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial'. Together they form a unique fingerprint.